CYP46A1 and the APOEε4 Allele Polymorphisms Correlate with the Risk of Alzheimer’s Disease

Cholesterol in myelin biogenesis and hypomyelinating disorders

(2015) Gesine Saher et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy

(2013) Chia-Chen Liu et al.   Nature Reviews Neurology

An Intronic CYP46A1 Polymorphism Is Associated with Alzheimer Disease in a Chinese Han Population

(2012) Xiao-ming He et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

CYP46A1 T/C polymorphism associated with the APOEε4 allele increases the risk of Alzheimer’s disease

(2012) Ling Li et al.   JOURNAL OF NEUROLOGY

Interaction of a β-sheet breaker peptide with lipid membranes

(2010) Giuseppe Vitiello et al.   JOURNAL OF PEPTIDE SCIENCE

CYP46A1 variants influence Alzheimer's disease risk and brain cholesterol metabolism

(2009) Heike Kölsch et al.   EUROPEAN PSYCHIATRY

Cyp46 Polymorphisms in Alzheimer’s Disease: A Review

(2009) Anália Nusya Medeiros Garcia et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease

(2009) Ian J. Martins et al.   JOURNAL OF NEUROCHEMISTRY

Cyp46-mediated cholesterol loss promotes survival in stressed hippocampal neurons

(2009) Mauricio G. Martin et al.   NEUROBIOLOGY OF AGING

Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease

(2009) Alina Solomon et al.   NEUROSCIENCE LETTERS

Interaction between Alzheimer's Aβ(25–35) peptide and phospholipid bilayers: The role of cholesterol

(2008) Gerardino D'Errico et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES